Abstract
Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) had caused catastrophic losses in swine industry in China. The current inactivated vaccine provided only limited protection, and the attenuated live vaccine could protect piglets against the HP-PRRSV but there was a possibility that the attenuated virus returned to high virulence. In this study, the eukaryotic expression vector pVAX1© was modified under the control of rabbit β-globin intron II gene and the modified vector pMVAX1© was constructed. Porcine interleukin-2 (IL-2) and GP3-GP5 fusion protein of HP-PRRSV strain SD-JN were highly expressed by pMVAX1©. Mice inoculated with pMVAX1©-GP35 developed significantly higher PRRSV-specific antibody responses and T cell proliferation than those vaccinated with pVAX1©-GP35. pMVAX1©-GP35 was selected as PRRS DNA vaccine candidate and co-administrated with pVAX1©-IL-2 or pMVAX1©-IL-2 in pigs. pMVAX1©-IL-2+pMVAX1©-GP35 could provide enhanced PRRSV-specific antibody responses, T cell proliferation, Th1-type and Th2-type cytokine responses and CTL responses than pMVAX1©-GP35 and pVAX1©-IL-2+pMVAX1©-GP35. Following homologous challenge with HP-PRRSV strain SD-JN, similar with attenuated PRRS vaccine group, pigs inoculated with pMVAX1©-IL-2+pMVAX1©-GP35 showed no clinical signs, almost no lung lesions and no viremia, as compared to those in pMVAX1©-GP35 and pVAX1©-IL-2+pMVAX1©-GP35 groups. It indicated that pMVAX1©-IL-2 effectively increases humoral and cell mediated immune responses of pMVAX1©-GP35. Co-administration of pMVAX1©-IL-2 and pMVAX1©-GP35 might be attractive candidate vaccines for preventing HP-PRRSV infections.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Viral / blood
-
Antibodies, Viral / immunology
-
Blotting, Western
-
Cell Proliferation
-
Cytokines / immunology
-
Cytokines / metabolism
-
Female
-
Gene Expression / immunology
-
Genetic Vectors / genetics
-
Glycoproteins / genetics
-
Glycoproteins / immunology
-
Glycoproteins / metabolism
-
HEK293 Cells
-
Humans
-
Immunity, Cellular / immunology
-
Immunity, Humoral / immunology
-
Interleukin-2 / genetics
-
Interleukin-2 / immunology*
-
Interleukin-2 / metabolism
-
Introns / genetics
-
Lymphocytes / immunology
-
Lymphocytes / metabolism
-
Mice, Inbred BALB C
-
Porcine Reproductive and Respiratory Syndrome / immunology*
-
Porcine Reproductive and Respiratory Syndrome / prevention & control
-
Porcine Reproductive and Respiratory Syndrome / virology
-
Porcine respiratory and reproductive syndrome virus / genetics
-
Porcine respiratory and reproductive syndrome virus / immunology*
-
Porcine respiratory and reproductive syndrome virus / metabolism
-
Rabbits
-
Reverse Transcriptase Polymerase Chain Reaction
-
Swine
-
Vaccines, DNA / administration & dosage
-
Vaccines, DNA / genetics
-
Vaccines, DNA / immunology*
-
Viral Proteins / genetics
-
Viral Proteins / immunology
-
Viral Proteins / metabolism
-
beta-Globins / genetics
Substances
-
Antibodies, Viral
-
Cytokines
-
Glycoproteins
-
Interleukin-2
-
Vaccines, DNA
-
Viral Proteins
-
beta-Globins
Grants and funding
This work was supported by the National Natural Science Foundation (31170146, 31100119 and 31370189), Special Fund for Agro-scientific Research in the Public Interest (201303046), Research Award Fund for Outstanding Young Scientist of Shandong Province (BS2012NY012), a grant from the China Postdoctoral Science Foundation (2012M521341), and Shandong Province Postdoctoral Special Fund for Innovative Projects (201203036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.